{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:39:06Z","timestamp":1790987946504,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.neuropharm.2004.06.021","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T14:27:23Z","timestamp":1095172043000},"page":"47-60","source":"Crossref","is-referenced-by-count":87,"special_numbering":"S1","title":["Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules"],"prefix":"10.1016","volume":"47","author":[{"suffix":"Jr.","given":"William A.","family":"Carlezon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Konradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2004.06.021_BIB1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00001756-199704140-00034","article-title":"Sex differences in dopamine receptor overproduction and elimination","volume":"8","author":"Andersen","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nn777","article-title":"Altered responsiveness to cocaine in rats exposed to methylphenidate during early development","volume":"5","author":"Andersen","year":"2002","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pmic.200390053","article-title":"Protein\u2013protein interactions as a target for drugs in proteomics","volume":"3","author":"Archakov","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1098-2396(199908)33:2<118::AID-SYN2>3.0.CO;2-L","article-title":"Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs","volume":"33","author":"Atkins","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00444692","article-title":"Evidence that the aversive effects of opioid antagonists and \u043a-agonists are centrally mediated","volume":"98","author":"Bals-Kubik","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0165-6147(02)02086-2","article-title":"A \u2018crash\u2019 course on psychostimulant withdrawal as a model of depression","volume":"23","author":"Barr","year":"2003","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB7","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1073\/pnas.172091899","article-title":"CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli","volume":"99","author":"Barrot","year":"2002","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00001756-199310000-00014","article-title":"Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system","volume":"5","author":"Beitner-Johnson","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/00004583-199808000-00016","article-title":"Caffeine withdrawal in normal school-age children","volume":"37","author":"Bernstein","year":"1998","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(01)00181-8","article-title":"Caffeine dependence in teenagers","volume":"66","author":"Bernstein","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB11","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1542\/peds.104.2.e20","article-title":"Pharmacotherapy of attention deficit\/hyperactivity disorder reduces risk for substance use disorder","volume":"104","author":"Biederman","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-3806(98)00116-3","article-title":"Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis","volume":"111","author":"Bola\u00f1os","year":"1998","journal-title":"Brain Res. Dev. Brain Res"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0006-3223(03)00570-5","article-title":"Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood","volume":"54","author":"Bola\u00f1os","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0893-133X(01)00281-0","article-title":"Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats","volume":"25","author":"Brandon","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB15","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0006-3223(03)00787-X","article-title":"Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons","volume":"54","author":"Brandon","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF02247398","article-title":"Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus","volume":"125","author":"Cabib","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB17","first-page":"243","article-title":"Place conditioning to study drug reward and aversion","volume":"84","author":"Carlezon","year":"2003","journal-title":"Methods Mol. Med"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0166-2236(02)02289-0","article-title":"Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?","volume":"25","author":"Carlezon","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.277.5327.812","article-title":"Sensitization to morphine induced by viral-mediated gene transfer","volume":"277","author":"Carlezon","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB20","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","article-title":"Regulation of cocaine reward by CREB","volume":"282","author":"Carlezon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevNeurobiol.v14.i1.30","article-title":"Viral-mediated gene transfer as a tool for neuropsychiatric research","volume":"14","author":"Carlezon","year":"2000","journal-title":"Crit. Rev. Neurobiol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB22","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.biopsych.2003.08.020","article-title":"Enduring behavioral effects of early exposure to methylphenidate in rats","volume":"54","author":"Carlezon","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB23","series-title":"The Neuropharmacological Basis of Reward","first-page":"264","article-title":"Conditioned place preference as a measure of drug reward","author":"Carr","year":"1989"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB25","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1523\/JNEUROSCI.17-13-04933.1997","article-title":"Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments","volume":"17","author":"Chen","year":"1997","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/mol.54.3.495","article-title":"Transgenic animals with inducible, targeted gene expression in brain","volume":"54","author":"Chen","year":"1998","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0896-6273(95)90225-2","article-title":"Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum","volume":"14","author":"Cole","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00426372","article-title":"Prediction of abuse liability of drugs using IV self-administration by rats","volume":"82","author":"Collins","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng0502-19","article-title":"GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways","volume":"31","author":"Dahlquist","year":"2002","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","article-title":"Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum","volume":"4","author":"Daunais","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB31","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF00442804","article-title":"Conditioned place aversion produced by FG 7142 is attenuated by haloperidol","volume":"99","author":"Di Scala","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB33","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/gb-2003-4-1-r7","article-title":"MAPPfinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data","volume":"4","author":"Doniger","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB34","first-page":"781","article-title":"FG 7142 and its anxiety-inducing effects in humans","volume":"23","author":"Dorow","year":"1987","journal-title":"Br. J. Clin. Pharmacol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB35","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.mp.4001016","article-title":"Synaptic plasticity and mood disorders","volume":"7","author":"Duman","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/NMM:5:1:011","article-title":"Role of neurotrophic factors in the etiology and treatment of mood disorders","volume":"5","author":"Duman","year":"2004","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB37","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.22-09-03312.2002","article-title":"Psychomotor stimulant addiction: a neural systems perspective","volume":"22","author":"Everitt","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1523\/JNEUROSCI.16-01-00274.1996","article-title":"Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents","volume":"16","author":"Fitzgerald","year":"1996","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-3806(89)90065-5","article-title":"Postnatal development of dopamine D1 and D2 receptor sites in rat striatum","volume":"49","author":"Gelbard","year":"1989","journal-title":"Brain Res. Dev. Brain Res"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB40","series-title":"Transitions during Adolescence: Interpersonal Domains and Context","first-page":"23","article-title":"Pubertal processes: methods, measures, and models","author":"Graber","year":"1996"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopsych.2003.08.008","article-title":"Chronic treatment with atypical neuroleptics induces striosomal FosB\/DeltaFosB expression in rats","volume":"55","author":"Grande","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB42","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1523\/JNEUROSCI.23-03-00742.2003","article-title":"Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving","volume":"23","author":"Grimm","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-8223(99)00106-6","article-title":"Soft drink consumption among US children and adolescents: nutritional consequences","volume":"99","author":"Harnack","year":"1999","journal-title":"J. Am. Diet. Assoc"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0959-4388(03)00107-7","article-title":"Chipping away at brain function: mining for insights with microarrays","volume":"13","author":"Henry","year":"2003","journal-title":"Curr. Opin. Neurobiol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K","article-title":"Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum","volume":"374","author":"Hiroi","year":"1996","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB46","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/nm964","article-title":"Local gene knockdown in the brain using viral-mediated RNA interference","volume":"9","author":"Hommel","year":"2003","journal-title":"Nat. Med"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00001756-199101000-00013","article-title":"Caffeine exposure sensitizes rats to the reinforcing effects of cocaine","volume":"2","author":"Horger","year":"1991","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/syn.890130408","article-title":"Molecular alterations in the neostriatum of human cocaine addicts","volume":"13","author":"Hurd","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB49","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2003.10.003","article-title":"Methylphenidate-induced plasticity: what should we be looking for?","volume":"54","author":"Hyman","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB50","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1523\/JNEUROSCI.21-07-02404.2001","article-title":"Long-term memory is facilitated by cAMP response-element binding protein overexpression in the amygdala","volume":"21","author":"Josselyn","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0173(91)90007-U","article-title":"Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity","volume":"16","author":"Kalivas","year":"1991","journal-title":"Brain Res. Brain Res. Rev"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/45790","article-title":"Expression of the transcription factor \u0394FosB in the brain controls sensitivity to cocaine","volume":"401","author":"Kelz","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-3223(01)01267-7","article-title":"Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia","volume":"50","author":"Konradi","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB54","first-page":"137","article-title":"Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotion or conditioned place aversion","volume":"269","author":"Kosten","year":"1994","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s002130050138","article-title":"Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure","volume":"128","author":"Kosten","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB56","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1523\/JNEUROSCI.22-16-07264.2002","article-title":"Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine","volume":"22","author":"Kuczenski","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn1301","article-title":"Structural plasticity and memory","volume":"5","author":"Lamprecht","year":"2004","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB58","first-page":"345","article-title":"Cocaine sensitization in periadolescent and adult rats","volume":"275","author":"Laviola","year":"1995","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00451687","article-title":"Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine","volume":"98","author":"Lett","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-003-1486-y","article-title":"Adolescent-onset nicotine self-administration modeled in female rats","volume":"169","author":"Levin","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/35093537","article-title":"Conditional control of gene expression in the mouse","volume":"2","author":"Lewandoski","year":"2001","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.011404098","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(94)90559-2","article-title":"U50,488, a \u03ba opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats","volume":"181","author":"Maisonneuve","year":"1994","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB65","first-page":"5","article-title":"Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics","volume":"35","author":"Manji","year":"2001","journal-title":"Psychopharmacol. Bull"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB66","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2003.207.pe49","article-title":"Signal transduction and genes-to-behaviors pathways in psychiatric diseases","author":"Manji","year":"2003","journal-title":"Sci. STKE"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0278-5846(00)00098-1","article-title":"Effects of cocaine self-administration on plasma corticosterone in rats: relationship to hippocampal type II glucocorticoid receptors","volume":"24","author":"Mantsch","year":"2000","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB68","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02245878","article-title":"Desmethylimipramine attenuates cocaine withdrawal in rats","volume":"109","author":"Markou","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s002130050530","article-title":"Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule","volume":"135","author":"Mendrek","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0031-9384(86)90388-4","article-title":"The curve-shift paradigm in self-stimulation","volume":"37","author":"Miliaressis","year":"1986","journal-title":"Physiol. Behav"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neubiorev.2003.11.004","article-title":"Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration","volume":"27","author":"Morgan","year":"2004","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB73","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"DeltaFosB: a sustained molecular switch for addiction","volume":"98","author":"Nestler","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0006-3223(02)01405-1","article-title":"Preclinical models: status of basic research in depression","volume":"52","author":"Nestler","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB76","series-title":"Behavioral Medicine and Women: A Comprehensive Handbook","first-page":"45","article-title":"Adolescence","author":"Petersen","year":"1998"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB77","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.2781295","article-title":"Factors that predict individual vulnerability to amphetamine self-administration","volume":"245","author":"Piazza","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB78","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1523\/JNEUROSCI.20-11-04226.2000","article-title":"Vertical shifts in self-administration dose\u2013response functions predict a drug-vulnerable phenotype predisposed to addiction","volume":"20","author":"Piazza","year":"2000","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","article-title":"A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants","volume":"25","author":"Pierce","year":"1997","journal-title":"Brain Res. Brain Res. Rev"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB80","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1542\/peds.111.1.42","article-title":"Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders","volume":"111","author":"Pollack","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB82","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB83","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","article-title":"Incentive-sensitization and addiction","volume":"96","author":"Robinson","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB85","first-page":"447","article-title":"Caffeine preexposure sensitizes rats to the motor activating effects of cocaine","volume":"1","author":"Schenk","year":"1990","journal-title":"Behav. Pharmacol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB86","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(96)00450-9","article-title":"Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists","volume":"57","author":"Shippenberg","year":"1997","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB87","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/dev.420160203","article-title":"Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats","volume":"16","author":"Spear","year":"1983","journal-title":"Dev. Psychobiol"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB89","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/pmic.200300434","article-title":"Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology","volume":"3","author":"Steinberg","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB90","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(90)90106-E","article-title":"Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal","volume":"37","author":"Stinus","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB91","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1523\/JNEUROSCI.19-05-01804.1999","article-title":"Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell","volume":"19","author":"Svingos","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB92","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1523\/JNEUROSCI.19-02-00610.1999","article-title":"Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms","volume":"19","author":"Takahashi","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB93","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00004583-199603000-00015","article-title":"Objective measurement of hyperactivity and attentional problems in ADHD","volume":"35","author":"Teicher","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB94","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa opioid ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0896-6273(02)00645-1","article-title":"Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala","volume":"34","author":"Tsvetkov","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB96","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-8993(96)01316-9","article-title":"Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization","volume":"749","author":"Turgeon","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0079-6123(08)62680-1","article-title":"The development of the rat prefrontal cortex. Its size and development of connections with thalamus, spinal cord and other cortical areas","volume":"85","author":"van Eden","year":"1990","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB98","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB99","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.biopsych.2003.10.019","article-title":"What are the long-term effects of methylphenidate treatment?","volume":"54","author":"Volkow","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0091-3057(01)00698-0","article-title":"The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction","volume":"71","author":"Walker","year":"2002","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB102","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive drugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB103","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol. Rev"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev.biochem.72.121801.161511","article-title":"Proteomics","volume":"72","author":"Zhu","year":"2003","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.neuropharm.2004.06.021_BIB105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers","volume":"283","author":"Zito","year":"2000","journal-title":"J. Am. Med. Assoc"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804001820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804001820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T19:23:49Z","timestamp":1549221829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390804001820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":105,"alternative-id":["S0028390804001820"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.06.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}